Journals / Turkish Journal of Medical Sciences / 2015 / Cilt: 45 - Sayı: 3

Prevention of methotrexate-induced nephrotoxicity by concomitantadministration of garlic aqueous extract in rat

Pages
507–516
Publication Date
2015-08-13
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Garlic treatment has a reversible biochemical and histological effect upon MTX-induced nephrotoxicity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Methotrexate (MTX) has been widely used for treatment of cancer and rheumatoid arthritis, but its use has been limited by its nephrotoxicity.
📊
Key Findings & Data:Materials and methods: Nephrotoxicity was induced in rats after a single i.p. injection of MTX (20 mg/kg).
💡
Conclusion & Impact:Conclusion: Garlic treatment has a reversible biochemical and histological effect upon MTX-induced nephrotoxicity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Garlic extract · methotrexate · nephrotoxicity

Abstract

Background/aim: Methotrexate (MTX) has been widely used for treatment of cancer and rheumatoid arthritis, but its use has been limited by its nephrotoxicity. This study was carried out to determine whether garlic exerts a protective effect against MTX-induced nephrotoxicity. Materials and methods: Nephrotoxicity was induced in rats after a single i.p. injection of MTX (20 mg/kg). Garlic extract (1 mL/100 g b.w.) was given orally for 7 days before and after MTX administration. Serum samples were collected to evaluate urea, creatinine, sodium, phosphorous, potassium, and calcium. Reduced glutathione, catalase, adenosine deaminase, nitric oxide, and malondialdehyde were measured in renal tissue. Tubular injury was evaluated by histopathological examination. Results: MTX increased urea and creatinine levels and led to imbalances in some electrolytes. It also depleted renal antioxidant enzyme levels and increased malondialdehyde, adenosine deaminase, and nitric oxide levels. Histopathological examination showed glomerular and tubular alterations. Pretreatment with garlic significantly improved renal function and increased renal antioxidant enzyme activities. Furthermore, garlic reduced renal oxidative stress and prevented alterations in renal morphology. Conclusion: Garlic treatment has a reversible biochemical and histological effect upon MTX-induced nephrotoxicity.

Özet

Background/aim: Methotrexate (MTX) has been widely used for treatment of cancer and rheumatoid arthritis, but its use has been limited by its nephrotoxicity. This study was carried out to determine whether garlic exerts a protective effect against MTX-induced nephrotoxicity. Materials and methods: Nephrotoxicity was induced in rats after a single i.p. injection of MTX (20 mg/kg). Garlic extract (1 mL/100 g b.w.) was given orally for 7 days before and after MTX administration. Serum samples were collected to evaluate urea, creatinine, sodium, phosphorous, potassium, and calcium. Reduced glutathione, catalase, adenosine deaminase, nitric oxide, and malondialdehyde were measured in renal tissue. Tubular injury was evaluated by histopathological examination. Results: MTX increased urea and creatinine levels and led to imbalances in some electrolytes. It also depleted renal antioxidant enzyme levels and increased malondialdehyde, adenosine deaminase, and nitric oxide levels. Histopathological examination showed glomerular and tubular alterations. Pretreatment with garlic significantly improved renal function and increased renal antioxidant enzyme activities. Furthermore, garlic reduced renal oxidative stress and prevented alterations in renal morphology. Conclusion: Garlic treatment has a reversible biochemical and histological effect upon MTX-induced nephrotoxicity.

🔖

Cite This Article

AHMED, W., ZAKI, A., NABIL, T. (2015). Prevention of methotrexate-induced nephrotoxicity by concomitantadministration of garlic aqueous extract in rat. Turkish Journal of Medical Sciences, Cilt: 45 - Sayı: 3, 507–516. https://ajindex.com/articles/113922

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med 1983; 309: 1094–1104.
  2. Kolli W, Abraham P, Isaac B, Selvakumar D. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage. Chemotherapy 2009; 55: 83–90.
  3. Hempel L, Misselwitz J, Fleck C, Kentouche K, Leder C, Appenroth D, Rost M, Zintl F. Influence of high dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function. Med Pediatr Oncol 2003; 40: 348–354.
  4. Izzedine H, Launay-Vacher V, Karie S, Caramella C, de Person F, Deray G. Is low-dose methotrexate nephrotoxic? Case report and review of the literature. Clin Nephrol 2005; 64: 315–319. Djerassi I. High-dose methotrexate (NSC-740) and citrovorum factor (NSC-3590) rescue: background and rationale. Cancer Chemother Rep 1975; 6: 3–6.
  5. Frei E, Blum RH, Pitman SW, Kirkwood JM, Henderson IC, Skarin AT, Mayer RM, Bast RC, Garnick MB, Parker LM et al. High dose methotrexate with leucovorin rescue: rationale and spectrum of antitumor activity. Am J Med 1980; 68: 370–376.
  6. Neuman MG, Cameron RG, Haber JA, Katz GG, Malkiewicz IM, Shear NH. Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytotoxicity. Clin Biochem 1999; 32: 519–536. 8. Perazella MA, Moeckel GW. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy. Semin Nephrol 2010; 30: 570–581.
  7. Gressier B, Lebegue S, Brunet C, Luyckx M, Dine T, Cazin M, Cazin JC. Pro-oxidant properties of methotrexate: evaluation and prevention by an anti-oxidant drug. Die Pharmazie 1994; 49: 679–681.
  8. Aggarwal P, Naik S, Mishra K, Aggarwal A, Misra R. Correlation between methotrexate efficacy & toxicity with C677T polymorphism of the methylenetetrahydrofolate gene in rheumatoid arthritis patients on folate supplementation. Indian J Med Res 2006; 124: 521–526.
  9. Capel I, Leach D, Dorrell H. Vitamin E retards the lipoperoxidation resulting from anticancer drug administration. Anticancer Res 1982; 3: 59–62.
  10. Kröger H, Hauschild A, Ohde M, Bache K, Voigt W, Thefeldt W, Krüger D. Nicotinamide and methionine reduce the liver toxic effect of methotrexate. Gen Pharmacol 1999; 33: 203–206.
  11. Jahovic N, Çevik H, Şehirli AÖ, Yeğen BÇ, Şener G. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res 2003; 34: 282–287.
  12. Öktem F, Yilmaz HR, Ozguner F, Olgar S, Ayata A, Uzar E, Uz E. Methotrexate-induced renal oxidativ